ArticleMolecular cancer therapeutics2017

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Saima Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.